Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 12c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.64), $0.12 better than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Sharon AI secures six-year compute deal with NVIDIA for Australia deployment
• BIG3 Basketball to go public via Graf Global merger at $290 million